Zhilei Li

机构：University of Science and Technology of China, Southern University of Science and Technology, Lanzhou University Second Hospital, Shanghai East Hospital, Lanzhou University · ORCID：0000-0003-3439-0986

发表论文 30 篇 · 总被引 418 次 · h-index 14

代表论文

• Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions (2022 · International Immunopharmacology · 被引 55)
• A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine (2022 · The Journal of Headache and Pain · 被引 53)
• Stepwise increase of thaxtomins production in Streptomyces albidoflavus J1074 through combinatorial metabolic engineering (2021 · Metabolic Engineering · 被引 38)
• Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer (2021 · Cancer Cell International · 被引 23)
• Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus (2020 · Applied Health Economics and Health Policy · 被引 22)
• White matter and cortical gray matter microstructural abnormalities in new daily persistent headache: a NODDI study (2024 · The Journal of Headache and Pain · 被引 19)